Download PDF
Skull Base 2010; 20(1): 005-010
DOI: 10.1055/s-0029-1242978
REVIEW ARTICLE

© Thieme Medical Publishers

Instruments for Estimation of Health-Related Quality of Life in Patients with Skull Base Neoplasms

Mariana E. Witgert1 , Tracy Veramonti1 , Ehab Hanna2
  • 1Department of Neuro-Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • 2Department of Head and Neck Surgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas
Further Information

Publication History

Publication Date:
22 January 2010 (online)

    Permissions and Reprints

ABSTRACT

With advances in treatment of patients with tumors of the skull base and associated improvement in length of survival, the need for assessment of quality of life (QOL) is becoming increasingly apparent. A thorough assessment of QOL, including functional, physical, social, and emotional status, as well as disease-specific symptoms, allows for comparison of treatments and informs treatment decisions. In addition, it allows for problems following intervention to be identified and addressed, thereby assisting patients in their pursuits of returning to their normal activities and level of functioning. Although health care providers and researchers are increasingly aware of the need to assess patients' QOL, few standardized measures exist with which to perform a comprehensive assessment of QOL in patients with skull base neoplasms. Further research is needed, including prospective trials using reliable and valid measures tapping various aspects of QOL and specific symptoms unique to patients with tumors of the skull base.

KEYWORDS

Skull base tumor - quality of life

REFERENCES

  • 1 Gil Z, Abergel A, Spektor S, Shabtai E, Khafif A, Fliss D M. Development of a cancer-specific anterior skull base quality-of-life questionnaire.  J Neurosurg. 2004;  100 813-819
    CrossrefPubMedGoogle Scholar
  • 2 Meyers C A, Geara F, Wong P, Morrison W H. Neurocognitive effects of therapeutic irradiation for base of skull tumors.  Int J Radiat Oncol Biol Phys. 2000;  46 51-55
    CrossrefPubMedGoogle Scholar
  • 3 Cusimano M D. Quality-of-life assessment in patients with lesions of the cranial base.  Skull Base Surg. 1999;  9 259-264
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Meyers C A, Hess K R. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression.  Neuro-oncol. 2003;  5 89-95
    PubMedGoogle Scholar
  • 5 Murphy B A, Ridner S, Wells N, Dietrich M. Quality of life research in head and neck cancer: a review of the current state of the science.  Crit Rev Oncol Hematol. 2007;  62 251-267
    CrossrefPubMedGoogle Scholar
  • 6 Gil Z, Abergel A, Spektor S, Khafif A, Fliss D M. Patient, caregiver, and surgeon perceptions of quality of life following anterior skull base surgery.  Arch Otolaryngol Head Neck Surg. 2004;  130 1276-1281
    CrossrefPubMedGoogle Scholar
  • 7 Yugueros P, Finical S J, Johnson C H. Use of microvascular free-tissue transfer following ablative surgery of the skull base.  J Reconstr Microsurg. 2000;  16 3-6
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Natarajan S K, Sekhar L N, Schessel D, Morita A. Petroclival meningiomas: multimodality treatment and outcomes at long-term follow-up.  Neurosurgery. 2007;  60 965-979 discussion 979-981
    PubMedGoogle Scholar
  • 9 Lang D A, Honeybul S, Neil-Dwyer G, Evans B T, Weller R O, Gill J. The extended transbasal approach: clinical applications and complications.  Acta Neurochir (Wien). 1999;  141 579-585
    CrossrefPubMedGoogle Scholar
  • 10 Mathiesen T, Gerlich Å, Kihlström L, Svensson M, Bagger-Sjöbäck D. Effects of using combined transpetrosal surgical approaches to treat petroclival meningiomas.  Neurosurgery. 2007;  60 982-991 discussion 991-992
    PubMedGoogle Scholar
  • 11 Raso J L, Gusmão S. Transbasal approach to skull base tumors: evaluation and proposal of classification.  Surg Neurol. 2006;  65(Suppl 1) S1:33-S1:37 discussion 1:37-1:38
    PubMedGoogle Scholar
  • 12 Roser F, Ebner F H, Ritz R, Samii M, Tatagiba M S, Nakamura M. Management of skull based meningiomas in the elderly patient.  J Clin Neurosci. 2007;  14 224-228
    CrossrefPubMedGoogle Scholar
  • 13 Ware Jr J E, Sherbourne C D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.  Med Care. 1992;  30 473-483
    CrossrefPubMedGoogle Scholar
  • 14 Neil-Dwyer G, Lang D A, Davis A. Outcome from complex neurosurgery: an evidence based approach.  Acta Neurochir (Wien). 2000;  142 367-371
    CrossrefPubMedGoogle Scholar
  • 15 Baumann I, Polligkeit J, Blumenstock G, Mauz P S, Zalaman I M, Maassen M M. Quality of life after unilateral acoustic neuroma surgery via middle cranial fossa approach.  Acta Otolaryngol. 2005;  125 585-591
    PubMedGoogle Scholar
  • 16 da Cruz M J, Moffat D A, Hardy D G. Postoperative quality of life in vestibular schwannoma patients measured by the SF36 Health Questionnaire.  Laryngoscope. 2000;  110 151-155
    CrossrefPubMedGoogle Scholar
  • 17 Kelleher M O, Fernandes M F, Sim D W, O'Sullivan M G. Health-related quality of life in patients with skull base tumours.  Br J Neurosurg. 2002;  16 16-20
    CrossrefPubMedGoogle Scholar
  • 18 Aaronson N K, Ahmedzai S, Bergman B et al.. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.  J Natl Cancer Inst. 1993;  85 365-376
    CrossrefPubMedGoogle Scholar
  • 19 Irving R M, Beynon G J, Viani L, Hardy D G, Baguley D M, Moffat D A. The patient's perspective after vestibular schwannoma removal: quality of life and implications for management.  Am J Otol. 1995;  16 331-337
    CrossrefPubMedGoogle Scholar
  • 20 Cella D F, Tulsky D S, Gray G et al.. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.  J Clin Oncol. 1993;  11 570-579
    PubMedGoogle Scholar
  • 21 DeMonte F. Functional outcomes in skull base surgery. What is acceptable?.  Clin Neurosurg. 2001;  48 340-350
    PubMedGoogle Scholar
  • 22 DeMonte F. Evolving role of skullbase surgery for patients with low and high grade malignancies.  J Neurooncol. 2004;  69 191-198
    CrossrefPubMedGoogle Scholar
  • 23 Hassan S J, Weymuller Jr E A. Assessment of quality of life in head and neck cancer patients.  Head Neck. 1993;  15 485-496
    CrossrefPubMedGoogle Scholar
  • 24 Rogers S N, Gwanne S, Lowe D, Humphris G, Yueh B, Weymuller Jr E A. The addition of mood and anxiety domains to the University of Washington quality of life scale.  Head Neck. 2002;  24 521-529
    CrossrefPubMedGoogle Scholar
  • 25 Martinez-Devesa P, Barnes M L, Alcock C J, Kerr R S, Milford C A. Evaluation of quality of life and psychiatric morbidity in patients with malignant tumours of the skull base.  J Laryngol Otol. 2006;  120 1049-1054
    PubMedGoogle Scholar
  • 26 Rigby P L, Shah S B, Jackler R K, Chung J H, Cooke D D. Acoustic neuroma surgery: outcome analysis of patient-perceived disability.  Am J Otol. 1997;  18 427-435
    PubMedGoogle Scholar
  • 27 Gil Z, Abergel A, Spektor S et al.. Quality of life following surgery for anterior skull base tumors.  Arch Otolaryngol Head Neck Surg. 2003;  129 1303-1309
    CrossrefPubMedGoogle Scholar
  • 28 Fliss D M, Abergel A, Cavel O, Margalit N, Gil Z. Combined subcranial approaches for excision of complex anterior skull base tumors.  Arch Otolaryngol Head Neck Surg. 2007;  133 888-896
    CrossrefPubMedGoogle Scholar
  • 29 Weitzner M A, Meyers C A, Gelke C K, Byrne K S, Cella D F, Levin V A. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.  Cancer. 1995;  75 1151-1161
    CrossrefPubMedGoogle Scholar
  • 30 Castellon S A, Ganz P A, Bower J E, Petersen L, Abraham L, Greendale G A. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.  J Clin Exp Neuropsychol. 2004;  26 955-969
    CrossrefPubMedGoogle Scholar
  • 31 Jenkins V, Shilling V, Deutsch G et al.. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.  Br J Cancer. 2006;  94 828-834
    CrossrefPubMedGoogle Scholar
  • 32 Schagen S B, Muller M J, Boogerd W, Van Dam F S. Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.  Clin Breast Cancer. 2002;  3(Suppl 3) S100-S108
    CrossrefPubMedGoogle Scholar
  • 33 Houston W S, Bondi M W. Potentially reversible cognitive symptoms in older adults. In: Attix KD, Welsh-Bomer K Geriatric Neuropsychology Assessment and Intervention. New York; Guilford Press 2006: 103-131
    PubMedGoogle Scholar
  • 34 Deschler D G, Walsh K A, Friedman S, Hayden R E. Quality of life assessment in patients undergoing head and neck surgery as evaluated by lay caregivers.  Laryngoscope. 1999;  109 42-46
    CrossrefPubMedGoogle Scholar
  • 35 Sneeuw KCA, Aaronson N K, Osoba D et al.. The use of significant others as proxy raters of the quality of life of patients with brain cancer.  Med Care. 1997;  35 490-506
    CrossrefPubMedGoogle Scholar

Ehab HannaM.D. F.A.C.S. 

Professor and Vice Chairman, Department of Head and Neck Surgery, University of Texas M. D. Anderson Cancer Center

1515 Holcombe Boulevard, Unit 441, Houston, TX 77030-4009

Email: eyhanna@mdanderson.org

      >